Recurrent miscarriage: evidence to accelerate action. Issue 10285 (1st May 2021)

• Record Type: Journal Article
• Authors: Coomarasamy, Arri; Dhillon-Smith, Rima K; Papadopoulou, Argyro; Al-Memar, Maya; Brewin, Jane; Abrahams, Vikki M; Maheshwari, Abha; Christiansen, Ole B; Stephenson, Mary D; Goddijn, Mariëtte; Oladapo, Olufemi T; Wijeyaratne, Chandrika N; Bick, Debra; Shehata, Hassan; Small, Rachel; Bennett, Phillip R; Regan, Lesley; Rai, Raj; Bourne, Tom; Kaur, Rajinder; Pickering, Oonagh; Brosens, Jan J; Devall, Adam J; Gallos, Ioannis D; Quenby, Siobhan
• Is Part Of: Lancet. Volume 397:Issue 10285(2021)
• Page Start: 1675
• Page End: 1682
• Publication Date: 2021-05-01
• Subjects: Medicine -- Periodicals; Medicine -- Periodicals; Medicine; Medicine; Electronic journals; Periodicals; 610.5
• DOI: 10.1016/S0140-6736(21)00681-4
• Languages: English
• ISSNs: 0140-6736

Abstract

Summary: Women who have had repeated miscarriages often have uncertainties about the cause, the likelihood of recurrence, the investigations they need, and the treatments that might help. Health-care policy makers and providers have uncertainties about the optimal ways to organise and provide care. For this Series paper, we have developed recommendations for practice from literature reviews, appraisal of guidelines, and a UK-wide consensus conference that was held in December, 2019. Caregivers should individualise care according to the clinical needs and preferences of women and their partners. We define a minimum set of investigations and treatments to be offered to couples who have had recurrent miscarriages, and urge health-care policy makers and providers to make them universally available. The essential investigations include measurements of lupus anticoagulant, anticardiolipin antibodies, thyroid function, and a transvaginal pelvic ultrasound scan. The key treatments to consider are first trimester progesterone administration, levothyroxine in women with subclinical hypothyroidism, and the combination of aspirin and heparin in women with antiphospholipid antibodies. Appropriate screening and care for mental health issues and future obstetric risks, particularly preterm birth, fetal growth restriction, and stillbirth, will need to be incorporated into the care pathway for couples with a history of recurrent miscarriage. We suggest health-care services structure care using a graded model in which women are offered online health-care advice and support, care in a nurse or midwifery-led clinic, and care in a medical consultant-led clinic, according to clinical needs.